Supporting the Company’s Global Expansion to Meet Growing Clinical and Biopharma Demand for Data-Driven Medicine SOPHiA GENETICS enters next stage of its global expansion with oversubscribed Series F round exceeding $110 million, led by major health-tech fund and followed by strategic industry leader Company demonstrates solidity of its business model with banks joining in the […]
ATLANTA — Lucid Scientific, the biotechnology tools company that develops and manufactures RESIPHER, announced the completion of a $3 million Series Seed financing led by Dynamk Capital. Additional participants include Lucid’s original investor base and the Georgia Research Alliance’s Venture Fund, bringing Lucid’s total funding to date to approximately $4.5 million. Proceeds from this round will help the company aggressively expand production, […]
Proceeds will be used for the further development and deployment of IONpath’s revolutionary MIBI technology, affirming its leadership in high-definition spatial proteomics MENLO PARK, Calif. — IONpath, Inc., the leader in high-definition spatial proteomics, today announced the close of a $18 million Series B financing led by Samsara BioCapital, and included participation from new investor […]
— PrognomIQ to develop multi-omics tests leveraging Seer’s Proteograph product — — Seer to retain minority ownership in PrognomIQ — Redwood City, CA — Seer, Inc., a life sciences company focused on enabling exceptional scientific outcomes through the power of unbiased, deep, rapid and scalable proteomics information, today announced that it has spun out and completed […]
Dräger Safety AG & Co. KGaA today announced that after an initial investment in the company in 2018, it has now made a follow-on equity investment in Kuva Systems. The Kuva platform is a camera-based methane monitoring solution centered on color-coded video clips of invisible gas that are automatically generated when emission events are detected. […]
Ansa Biotechnologies today announced that it has raised $7.9 million in an oversubscribed Seed round of funding led by Horizons Ventures, with participation from Mubadala Capital, Humboldt Fund, and additional investors. Combined with a Pre-Seed round raised in December 2018 led by Fifty Years, the company has raised $9.2 million to date. The new investment […]
The REPAIR project aims to develop a new approach and clinically applicable method in cardiac contraction assistance. Current medical or surgical treatments cannot restore muscular contractility in heart failure and atrial fibrillation, two of the most common and serious cardiac diseases. A revolutionary approach would be to use smart materials to support or restore cardiac mechanical […]
Major Life Sciences Investors Support Company’s Vision, Strengthen Its Position as the Leader in Genome Engineering for Rapid Therapeutic Discovery, Development and Manufacturing REDWOOD CITY, Calif. – Synthego, the genome engineering company, today announced that it raised $100 million in a Series D financing led by new investor Wellington Management, co-led by RA Capital Management and […]
Longmont, CO – KromaTiD, Inc. announced today that it was awarded a Direct to Phase II SBIR grant by the National Human Genome Research Institute. The award supports development of a structural variant discovery platform – dGH DSCVR™ – enabling efficient discovery of genomic structural causes of rare disease and measurement of unwanted structural rearrangements […]
aMoon leads round to expand product portfolio and advance commercial efforts for MOBILion’s SLIM technology for biotherapeutics characterization and novel biomarker discovery. Chadds Fords, PA. — MOBILion Systems, Inc., a pioneer in fast, efficient, high-resolution instrumentation for biomarker discovery, diagnostics and therapeutic development, today announced a $35 million Series B funding round. The oversubscribed round was […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
